Japanese chemical company to close Quebec COVID-19 vaccine manufacturer Medicago
The Japanese chemical company said Thursday it would stop marketing the Medicago-produced Covifenz vaccine, which is plant-based and was approved by Health Canada one year ago for adults aged 18 to 64.